Bonaccord Capital has made a passive minority investment in Revelstoke Capital Partners, a healthcare-focused private equity firm with $5.6 billion of assets under management.
Bonaccord, a subsidiary of P10, is a private equity platform dedicated to acquiring non-control equity interests in leading private markets investment firms.
Revelstoke has experienced significant growth since its founding in 2013, having raised three flagship private equity funds, three single-asset continuation vehicles under the EPIC series and numerous co-investment vehicles. Across these investment vehicles, Revelstoke has completed 184 acquisitions, which include 26 platform companies and 158 add-on acquisitions.
“We are proud to have established a strategic long-term partnership with Bonaccord, which we believe will be integral to Revelstoke’s continued growth and will allow us to increase our commitment to our funds, further enhancing our alignment with our limited partners,”